Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.

Brietzke E, Trevizol AP, Fries GR, Subramaniapillai M, Kapczinski F, McIntyre RS, Mansur RB.

J Psychiatr Res. 2018 Jul;102:186-191. doi: 10.1016/j.jpsychires.2018.04.012. Epub 2018 Apr 13.

PMID:
29680575
2.

Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.

Yu Y, Lin Y, Takasaki Y, Wang C, Kimura H, Xing J, Ishizuka K, Toyama M, Kushima I, Mori D, Arioka Y, Uno Y, Shiino T, Nakamura Y, Okada T, Morikawa M, Ikeda M, Iwata N, Okahisa Y, Takaki M, Sakamoto S, Someya T, Egawa J, Usami M, Kodaira M, Yoshimi A, Oya-Ito T, Aleksic B, Ohno K, Ozaki N.

Transl Psychiatry. 2018 Jan 10;8(1):12. doi: 10.1038/s41398-017-0061-y.

3.

Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy.

Bhakta SG, Chou HH, Rana B, Talledo JA, Balvaneda B, Gaddis L, Light GA, Swerdlow NR.

Psychopharmacology (Berl). 2016 Jun;233(12):2399-410. doi: 10.1007/s00213-016-4291-0. Epub 2016 Apr 13.

4.

Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.

Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2016 Jan;170(1):30-40. doi: 10.1016/j.schres.2015.11.008. Epub 2015 Nov 18. Review.

5.

Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population.

Zhang Y, Fan M, Wang Q, He G, Fu Y, Li H, Yu S.

Sci Rep. 2015 Aug 10;5:12984. doi: 10.1038/srep12984.

6.

A population-specific uncommon variant in GRIN3A associated with schizophrenia.

Takata A, Iwayama Y, Fukuo Y, Ikeda M, Okochi T, Maekawa M, Toyota T, Yamada K, Hattori E, Ohnishi T, Toyoshima M, Ujike H, Inada T, Kunugi H, Ozaki N, Nanko S, Nakamura K, Mori N, Kanba S, Iwata N, Kato T, Yoshikawa T.

Biol Psychiatry. 2013 Mar 15;73(6):532-9. doi: 10.1016/j.biopsych.2012.10.024. Epub 2012 Dec 11.

7.

Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.

Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, Piton A, Spiegelman D, Henrion É, Millet B; S2D team, Fathalli F, Joober R, Rapoport JL, DeLisi LE, Fombonne É, Mottron L, Forget-Dubois N, Boivin M, Michaud JL, Drapeau P, Lafrenière RG, Rouleau GA, Krebs MO.

Transl Psychiatry. 2011 Nov 15;1:e55. doi: 10.1038/tp.2011.52.

8.

Exomic sequencing of the ionotropic glutamate receptor N-methyl-D-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia.

Shen YC, Liao DL, Chen JY, Wang YC, Lai IC, Liou YJ, Chen YJ, Luu SU, Chen CH.

Schizophr Res. 2009 Oct;114(1-3):25-32. doi: 10.1016/j.schres.2009.07.005. Epub 2009 Aug 7.

PMID:
19665356
9.

Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.

Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH.

Am J Psychiatry. 2001 Sep;158(9):1393-9.

PMID:
11532723

Supplemental Content

Loading ...
Support Center